The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease-Reference-Cited by-同舟云学术

The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease

Published:2014-03-04 Issue:3 Volume:6 Page:934-949
ISSN:2072-6651
Container-title:Toxins
language:en
Short-container-title:Toxins

Author:

Sallée Marion,Dou Laetitia,Cerini Claire,Poitevin Stéphane,Brunet Philippe,Burtey Stéphane

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

http://www.mdpi.com/2072-6651/6/3/934/pdf

Reference108 articles.

1. Chronic kidney disease as cause of cardiovascular morbidity and mortality

2. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

3. Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care Organization

4. Vascular Incompetence in Dialysis Patients-Protein-Bound Uremic Toxins and Endothelial Dysfunction

5. Review on uremic toxins: Classification, concentration, and interindividual variability

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loop diuretics inhibit kynurenic acid production and kynurenine aminotransferases activity in rat kidneys;Pharmacological Reports;2024-09-11

2. Non-dialyzable uremic toxins and renal tubular cell damage in CKD patients: a systems biology approach;European Journal of Medical Research;2024-08-09

3. Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-08

4. Kynurenic Acid/AhR Signaling at the Junction of Inflammation and Cardiovascular Diseases;International Journal of Molecular Sciences;2024-06-25

5. The role of the kynurenine pathway in cardiovascular disease;Frontiers in Cardiovascular Medicine;2024-05-31